I am concerned about FDA decisions to allow Mifepristone to be distributed by mail and without physician supervision.
John Hoeven: “I am concerned about FDA decisions to allow Mifepristone to be distributed by mail and without physician supervision.”
Editor's note · Context
Hoeven expresses concern over mail distribution of Mifepristone without supervision.
Share
More from John Hoeven
We appreciate Under Secretary Haustveit for again visiting North Dakota with us to help move this initiative forward. The DOE has more than enough loan guarantee authority available to support phase two, and we’re working to ensure that…
These investments will help improve rail safety, increase efficiency and strengthen North Dakota’s transportation infrastructure.
Between Project ATLAS, which we announced yesterday, and the MOU signed today, it is clear to anyone who wants to develop drone and counter-drone technology, North Dakota is the place to be.
We appreciate their attendance at the UAS Summit, as it provides an opportunity to discover new avenues to leverage our expertise in unmanned technology to meet the defense challenges of tomorrow and keep moving the ball forward on our…





